Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2116)	4/1/2008 10:28:43 AM
From: Jibacoa	Respond to of 3722

CEGE was up 27.65% at its intraday H & still is up 21.6% on volume of 2,645,067 which is getting close to 2x its ADV. The stock opened with an UG after the CC yesterday in which it discussed its alliance with Takeda for the commercialization of GVAX bigcharts.marketwatch.com But so far the stock has found resistance at the $3 level & hasn't been able to retest its Feb 20 H of $3.38 which was obtained on volume of 11,598,000 when it announced the PII results of GVAX. bigcharts.marketwatch.com The stock remains on its long term DT coming from its March 2000 H of $61.75 <g> bigcharts.marketwatch.com Bernard